6431 — Kuangli Bio Tech Holdings Co Cashflow Statement
0.000.00%
Last trade - 00:00- TWD1.32bn
- TWD1.62bn
- TWD381.30m
Annual cashflow statement for Kuangli Bio Tech Holdings Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -59.5 | 49.5 | -84.8 | -124 | -182 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -15.4 | -71.4 | 12.8 | 16 | 45.3 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 75.6 | 3.61 | 2.02 | -15.3 | -12 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 8.5 | 21.7 | -9.24 | -62.4 | -65.2 |
| Capital Expenditures | -8.51 | -40.6 | -34.2 | -25.2 | -17.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -27 | -52.9 | 31.1 | -5.29 | 79.7 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -35.5 | -93.4 | -3.16 | -30.5 | 62.3 |
| Financing Cash Flow Items | — | 6.38 | -353 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.6 | 121 | -11.1 | 17.5 | -16.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -14.6 | 47.7 | -20.3 | -78.7 | -21.6 |